Expected earnings - Vivos Therapeutics Inc.
Source: US Earnings Reports
Vivos Therapeutics Inc. (VVOS) is expected to report $-0.39 for Q2 2025
Vivos Therapeutics Inc.
NASDAQ: VVOS
VVOS Trading
-3.73% G/L:
$1.29 Last:
112,675 Volume:
$1.27 Open:
VVOS Latest News
February 05, 2026 08:45:00 am
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies
January 20, 2026 05:31:09 pm
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 16, 2026 08:00:00 am
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
December 16, 2025 08:45:00 am
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
VVOS Stock Data
$16,280,184
8,040,995
N/A
7
N/A
Medical Equipment & Supplies
Healthcare
US
Littleton
